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1 Introduction
Management of severely affected isoimmunized
patients has traditionally involved intraperitoneal
transfusions if the fetal lungs are immature. How-
ever, the outcome of this procedure is doubtful in
cases of hydropic fetuses since they seem to have
an inadequate absorption of erythrocytes from the
peritoneal cavity. More recently, it has been re-
ported that direct intravascular transfusions in
utero can improve the outcome for this cathegory
of patients. The latter technique was pioneered by
RODECK et al [9] using a fetoscopic approach and
was later performed in a less combersome way by
BANG [1], who performed the transfusion under
ultrasonic guidance. Since then, the technique has
been introduced in many perinatal units [2 — 5, 8,
9, 11]. In Saudi Arabia severe rhesus isoimmuni-
zation is still a common perinatal problem and
one assumes that approximately 5 — 10% of the
perinatal mortility is related to blood group in-
compatibility [7]. The main reason for this is that
anti-D prophylaxis has not until recently been
widely implemented and that many women expe-
rience a high number of pregnancies. Furthermore,
many women at risk will not attend standardized
antenatal care and will not be recognized until
they are in an advanced stage of the disease. Con-
sequently, the isoimmunized patient presents a
rather common challange to the obstetrician prac-
ticing in this country. The aim of the present
investigation was to introduce and evalutate intra-
vascular transfusions in severe cases of rhesus
isoimmunization at KING FAISAL SPECIALIST HOS-
PITAL (KFSH) in Riyad.
2 Patients and methods
From May, 1986 to May, 1988, 41 patients with
severe rhesus isoimmunization and with a gesta-
tional age of less than 30 weeks were referred to
KFSH. Table I gives detailed information about
the patients.
According to the management protocol which was
approved by the Ethics and Research Committee
of KFSH, all patients were evaluated with fetal
blood sampling when entering the programme. In
case of fetal anaemia, intravascular transfusions
were carried out. These procedures were per-
formed as follows: the mother was sedated with
10 mg of intramuscular morphin and 25 mg of
promethazin one hour before the procedure. A 22
gauge preheparinized spinal needle was guided to
the cord insertion in the placenta or into the fetal
heart with the use of continuous ultrasound mon-
itor (Philips SDR 1500 sector scanner). According
to the protocol, cardiac transfusion should be car-
ried out when it was impossible to perform the
transfusion into the cord. However, during the
study period, with the introduction of new mem-
bers in the transfusion team, there was a tendency
to drift away from the original policy and during
the last year of the study, the cardiac approach
was the first choice in many cases.
A detailed description of the technique of intra-
cardiac transfusion has recently been published
[13]. After insertion of the needle, 3.0—4 ml of
fetal blood was drawn for analyis of haematolog-
ical indices (COULTER Counter 5 plus 3), acid-base
balance (Coning 178 pH blood gas analyzer) and
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Table I. Description of the rhesus isoimmininzed patients.
Past obstetrical history:

























ascites, pleura and pericardial effusion, subcutanous oedma, lack of fetal movements and spontanous bradychardia
KLEIHAUER-BETHKE test. The transfusion volume
was calculated according to the method described
by RODECK et al [10] and the aim was to raise the
haematocrit to 30%. However, at intracardiac
transfusions, due to fear of central overload and
technical difficulties to keep the needle in the cor-
rect position for a longer period, considerably
smaller blood volumes (5 — 35 ml) were adminis-
tered. Type 0, Rh negative, CMV antibody nega-
tive packed red cells were administered at a rate
of about 1 ml per minute. After the transfusion, a
post procedure sample was obtained for evalua-
tion of haemoglobin and acid base balance. Im-
mediately after the transfusion the fetal heart was
scanned for 15 minutes and the patient was later
monitored with cardiotochogram for another
hour. Subsequent transfusions were carried out at
3 — 15 days interval depending on the severity of
the anaemia and the ultrasonic appearance of the
fetus. In non-hydropic fetuses, the haematocrit
drop was assumed to be one point per day as
reported by RODECK et al [10] while in more severe
cases, according to our experience, the drop is
usually faster.
Later fetal surveillance included weekly ultra-
sound examinations and non stress tests. The aim
in each case was to enable the mother to carry her
pregnancy until at least the 31st week of gestation.
All patients were delivered at the KFSH and all
surviving infants were treated at the neonatal in-
tensive care unit of this hospital. Autopsy was
only permitted in two of the stillbirths.
3 Results
During the study period, 37 patients underwent a
total of 92 intravascular transfusions. Of these, 77
were intracardiac, 13 umbilical vein and two um-
bilical artery transfusions. Fetal blood sampling
without any transfusions were carried out 27 times
in these and the remaining four patients.
Table II presents the distribution of invasive fetal
procedures in relation to gestational age. Umbili-
cal transfusions were predominately performed in
fetuses with a gestational age of more than 25
weeks. Procedure related complications occurred
at eight (10%) intracardiac and two (13%) um-
bilical transfusions.
The complications and the consequences for the
fetus are presented in table III. In three patients,
increased amount of fluid in the pericardial space
could be observed immediately after the proce-
dure, suggesting haemopericardium. In one of
these cases it was possible to aspirate the blood
(previously described in detail [13]) while the other
two exspired soon after the transfusion. Post-mor-
tem examinations were performed revealing car-
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Table Π. Invasive fetal procedures in relation to gestational age (procedure related complications in brackets).
Gestational age (weeks):



























Table ΠΙ. Complications at intravascular transfusions and consequences for the fetus.
Complications Outcome
Patient 1: Fetal heart arrest at three consecutive intracardiac transfusions at 21, 23
and 24 weeks. After transfusion into the cord in the 26th week, bleeding
from puncture site
Patient 2: Haemopericardium at 3rd intracardiac transfusion, 7 ml blood was aspi-
rated. Delivered electivly 3 weeks later
Patient 3: Fetal tachycardia after cord transfusion at 29th week. Blood stained
amniotic fluid
Patient 4: Haemopericardium at the 6th intracardiac transfusion 30 weeks
Patient 5: Haemopericardium at 1st transfusion 26 weeks
Patient 6: Fetal heart arrest of unknown cause 4 hrs after intracardiac transfusion
in the 26th week




















diac tamponade. The clots in the pericardial space
consisted of sero-negative blood which, at least,
in one of the patients who had received a first
transfusion, indicated that the transfusion had
been wrongly administered into the pericardial
space. The other fetus with sero-negative blood
clot in the pericardium, had received its seventh
transfusion and it cannot be established if the
cardiac tamponade was due to an incorrectly
placed needle or bleeding from the heart after the
procedure. Two patients with cord transfusions
had signs of fetal bleeding from the puncture site
immediatly after the transfusion. It was possible
to deliver one of these patients (due to fetal tach-
ycardia) with emergency ceasarean section. The
other which was a case of fetal trombocytopenia
died the next day when it was found to be severely
anaemic. In one case of intracardiac and in an-
other of umbilical vein transfusion, the fetus died
within six hours after "technically uncomplicated"
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transfusions. Since none of these cases were se-
verely affected (preprocedure haemoglobin 47 and
52 g/1 respectively), we assumed that the cause of
death in these cases is related to the procedure.
Reversal of hydrops could be observed in 10 of
16 patients, three of whom were at a terminal
stage of the disease when they were transferred to
our unit. Two of these fetuses died soon after an
"uncomplicated transfusion".
One transfused fetus developed severe respiratory
distress syndrome soon after birth in the 31st week
of gestation and died. Thus, the perinatal mortal-
ity among transfused fetuses is 8/37 (21%) and in
the total material 8/41 (19%). Another 15 of 33
transfused infants developed moderate to severe
respiratory distress syndrom requiring assistant
ventilation during the neonatal period. Neonatal
exchange transfusions due to hyperbilirubinemia
were performed in 18/33 surviving infants. Ten
neonates required only one exchange transfusion,
six required three and two required five exchange
transfusions.
4 Discussion
Intrauterine, intravascular transfusion represents
the most recent mode of treatment for severe rhe-
sus isoimmunization. In the present patient pop-
ulation where all belonged to WHITFIELD'S group
D (at least one isoimmunized related death) [14],
the perinatal mortality was 21%. These results are
slightly poorer than the results reported by other
units working with intravascular transfusions but
is better than those reported on conventional in-
traperitoneal transfusions [6]. This applies espe-
cially to fetuses with hydrops fetalis while the value
of intravascular transfusions in cases of non-hy-
dropic fetuses remains to be established.
What distinguishes this study from previous stud-
ies is the use of intracardiac fetal transfusions. The
reason for this approach was the difficulties in
performing conventional chordocentesis with the
ultrasound equipment available. The results sug-
gest that this approach is problematic and is af-
flicted with several potentially dangerous compli-
cations. When blood is given directly into the
heart, the blood with high packed cell volume and
low pH may enter the coronary circulation which
may lead to arythmias and asystole. Furthermore,
if the surgeon is not perfectly aware of the position
of the needle tip, the blood can easily be admin-
istered into the pericardial space. After removal
of the needle, bleeding from the puncture site may
lead to haemipericardium and subsequent cardiac
tamponade. All these complications occurred in
the present study and they clearly illustrate the
potential danger of the procedure. Although com-
plications also occur at cord transfusions, the se-
verity of the complications at intracardiac trans-
fusions made us try to limit the use of this method
as much as possible. After being equipped with up
to date ultrasound units we are therefore at the
present time moving from cardio- to chordocen-
tesis. However, in the most immature cases, we
still feel that this method has a place and it should
be emphasized that no complications occurred at
simple fetal blood samplings.
Another fact that should be commented upon
when discussing complications at invasive fetal
procedures is the training of the transfusion team.
Five of six complications which led to fetal death
in the present study were caused by members of
the team who were in the process of learning.
When they later gained experience, the results im-
proved. Thus, although needling of the fetus is
well within the grasp of any capable obstetrical
ultrasonographer, training must be under close
supervision and the operator has to perform a
certain amount of procedures to gain sufficient
experience, thereby maximizing safety. Thus, per-
inatal care of severely Rh affected fetuses cannot
be acomplished in every hospital but should be
regionalized to a few institutions with an experi-
enced staff and where necessary equipment is
available.
A group of patients who obviously benefits from
intravascular transfusions are those with an early
onset of hydrops. In the present study, resolution
of hydrops was observed in 9/16 hydropic fetuses.
Similar results have been reported by others [5,
12]. In cases of so called terminal hydrops where
the fetus is at the end stage of the disease, most
cases are not salvagable. When calculating the
blood volume by haemoglobin haemodilution
technique, our results indicate that these fetuses
are hypervolaemic and we have therefore treated
them with frequent small top-up transfusions. By
this method it was possible to save one infant with
initial haemoglobin concentration of 20% of its
normal value. We speculate that larger blood vol-
umes or exchange transfusions will lead to circu-
latory overload in these cases.
Finally, intrauterine, intravascular transfusion is
a valuable method in the management of severly
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isoimmunized fetuses. Problems concerning tech-
nique and indications remain to be solved. So far,
there has been a paradoxal situation since this
service has been available in advanced centres in
countries where rhesus isoimmunization is quite a
rare problem. It is a challenging task in the future
to provide this mode of management also in coun-
tries where experience in fetal diagnosis and treat-
ment is rather limited but where rhesus isoimmun-
ization is still a major perinatal problem.
Abstract
Thirtyseven fetuses with severe rhesus isoimmunization
with a gestational age of less than 30 week underwent
92 intravascular transfusions. Of these, 77 were intra-
cardiac, 13 umbilical vein and two umbilical artery trans-
fusions. Procedure related complications ocurred at eight
(10%) intracardiac and at two (14%) umbilical cord
transfusions. Reversal of hydrops was observed in 10 of
16 fetuses. The perinatal mortality among transfusion
treated fetuses was 8/37 (21%). It is concluded that
intravascular, intrauterine transfusion leads to improved
results among fetuses with early onset of hydrops. Prob-
lems concerning indications and technique are discussed.
Keywords: Fetal therapy, prenatal diagnosis, Rh isoimmunization.
Zusammenfassung
Einführung eines Programms zur Therapie bei schwerer
Rhesus-Isoimmunisierung durch intravaskuläre Transfu-
sionen
In einem Zeitraum von zwei Jahren wurden 41 Patienten
mit schwerer Rhesus-Isoimmunisierung und einem Ge-
stationsalter unter 30 Wochen mit insgesamt 92 fetalen
intravaskulären Transfusionen behandelt bzw. punktiert.
Davon erfolgten 77 intracardial, 13 in die Nabelvene
und 2 in die Nabelarterie. Zusätzlich wurden 27 fetale
Blutproben entnommen. Bei den intracardialen Trans-
fusionen traten in 8 Fällen Komplikationen auf (10%),
bei den Transfusionen in die Nabelschnur in 2 Fällen
(14%). Diese Komplikationen werden detailliert be-
schrieben. Die perinatale Mortalität im Gesamtkollektiv
betrug 19% (8 von 41 Feten), die bei dem mit intravas-
kulären Transfusionen behandelten Kollektiv 21% (8
von 37 Feten). Bei 10 von 16 Feten wurde ein Rückgang
des Hydrops verzeichnet. Wir meinen, daß intrauterine,
intravaskuläre Transfusionen bei Feten mit früher Aus-
bildung eines Hydrops echte Erfolge bringen können.
Bei nicht-hydropischen Feten muß der therapeutische
Wert von intravaskulären Transfusionen noch genauer
untersucht werden. Hierzu sind prospektive, randomi-
sierte Studien notwendig, in denen das konventionelle
Verfahren mittels iniraperitonealer Transfusionen den
neuen Techniken gegenübergestellt wird. Probleme im
Hinblick auf Indikation, Zeitpunkt und technische Ein-
zelheiten bei intravaskulären Transfusionen werden dis-
kutiert.
Schlüsselwörter: Fetaltherapie, pränatale Diagnose, Rhesus-Isoimmunisierung.
Resume
Introduction d'un programme de transfusion intra-vascu-
laire lors des iso-immunisations rhesus graves
On a traite par 92 transfusions foetales intra-vasculaires
41 patientes presentant une iso-immunisation rhesus
grave et un äge gestationnel inferieur ä 30 semaines, sur
une periode de deux ans. Parmi ces transfusions 77 ont
etc realisees en intra-cardiaques, 13 dans la veine om-
bilical et 2 dans Fartere ombilicale. En outre, 27 prele-
vements de sang foetal ont ete effectues. II y a eu des
complications liees ä la technique au cours de 8 trans-
fusions intra-cardiaques (10%) et de 2 transfusions au
niveau du cordon ombilical (14%). Ces complications
sont decrites en detail.
La mortalite perinatale de Fensemble a ete de 8 su 41
(19%) et chez le patientes traitees par transfusion intra-
vasculaires de 8 sur 37 (21%).
La disparition de I'hydrops a ete observee chez 10 des
16 foetus. On en conclue que les transfusions in utero
intra-vasculaires ameliorent les resultats chez les foetus
avec hydrops d'apparition precoce. Pour les cas sans
hydrops la valeur des transfusions intra-vasculaires doit
etre plus verifiee et il y a besoin d'etudes radomisees
prospectives afin de comparer cette technique avec les
transfusions intra-peritoneales conventionnelles.
Les auteurs discutent les problemes concernant les in-
dications, la programmation et la technique en rapport
avec les transfusions intra-vasculaire.
Mots-cles: Diagnostic prenatal, incompatibilite thesus, therapeutique foetale.
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